Reshma Kewalramani, CEO & President: Vertex Pharmaceuticals VRTX Sell · Filed 03/03

Trade details

Type: Insider sale
Amount: $2,974,479.2
Shares · price: 5,995 sh · $496.16 a share
Held after: 100,003 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Reshma KewalramaniCEO & President
Trade date: 26/02/27
Filed: 26/03/03
Days to filing: 4 days

Sold 5.7% of holdings

Share of holding sold: 5.7%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/28~03/29

Reshma Kewalramani's recent trades

Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.7M
15,580 sh
$7.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.7M
3,498 sh
$1.7M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,278 sh
$1.6M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,725 sh
$1.3M
Filed 03/03
Traded 02/27
Reshma KewalramaniCEO & President
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,520 sh
$1.2M
Filed 03/03
Traded 02/27

Reshma Kewalramani, CEO — sold $3M of Vertex Pharmaceuticals VRTX · 5.7% of holdings · 10b5-1 plan | Whalegun